Search

Search Constraints

You searched for: Author/Creator Trazzi, Stefania

Search Results

2. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder. (20th February 2018)

3. Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome. (3rd September 2012)

4. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder. (27th May 2018)

6. ISDN2014_0057: Inhibition of GSK3‐beta rescues hippocampal development in a knockout mouse model of CDKL5 encephalopathy. Issue 47 (5th November 2015)

7. Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder. (1st May 2020)

8. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. (1st October 2016)

9. Treatment with the GSK3‐beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice. (16th April 2018)